220 related articles for article (PubMed ID: 33789109)
21. Overexpression of the truncated form of High Mobility Group A proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation.
Mas A; Cervelló I; Fernández-Álvarez A; Faus A; Díaz A; Burgués O; Casado M; Simón C
Mol Hum Reprod; 2015 Apr; 21(4):330-8. PubMed ID: 25542836
[TBL] [Abstract][Full Text] [Related]
22. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma.
Di Tommaso S; Tinelli A; Malvasi A; Massari S
Mol Hum Reprod; 2014 Oct; 20(10):1009-15. PubMed ID: 25015674
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis.
Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP
Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708
[TBL] [Abstract][Full Text] [Related]
24. Epigenome overlap measure (EPOM) for comparing tissue/cell types based on chromatin states.
Li WV; Razaee ZS; Li JJ
BMC Genomics; 2016 Jan; 17 Suppl 1(Suppl 1):10. PubMed ID: 26817822
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of tuberin in human uterine leiomyoma.
Cui L; Ren Y; Yin H; Wang Y; Li D; Liu M; Zhu Y; Lin W; Tang XD; Gui Y; Zheng XL
Fertil Steril; 2011 Apr; 95(5):1805-8. PubMed ID: 21145542
[TBL] [Abstract][Full Text] [Related]
26. Genomics of uterine leiomyomas: insights from high-throughput sequencing.
Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P
Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763
[TBL] [Abstract][Full Text] [Related]
27. PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes
Makker A; Goel MM; Mahdi AA; Bhatia V; Das V; Agarwal A; Pandey A
Indian J Med Res; 2016 May; 143(Supplement):S112-S119. PubMed ID: 27748285
[TBL] [Abstract][Full Text] [Related]
28. Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.
Joseph DS; Malik M; Nurudeen S; Catherino WH
Fertil Steril; 2010 Mar; 93(5):1500-8. PubMed ID: 19328471
[TBL] [Abstract][Full Text] [Related]
29. An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas.
Cirilo PD; Marchi FA; Barros Filho Mde C; Rocha RM; Domingues MA; Jurisica I; Pontes A; Rogatto SR
PLoS One; 2013; 8(3):e57901. PubMed ID: 23483937
[TBL] [Abstract][Full Text] [Related]
30. Leiomyoma phosphoproteins involved in inhibition of oxidative stress and synthesis of reactive oxygen species.
Ura B; Monasta L; Arrigoni G; Licastro D; Di Lorenzo G; Romano F; Gaita B; Scrimin F; Ricci G
Int J Mol Med; 2019 Dec; 44(6):2329-2335. PubMed ID: 31638170
[TBL] [Abstract][Full Text] [Related]
31. PEP-19 overexpression in human uterine leiomyoma.
Kanamori T; Takakura K; Mandai M; Kariya M; Fukuhara K; Kusakari T; Momma C; Shime H; Yagi H; Konishi M; Suzuki A; Matsumura N; Nanbu K; Fujita J; Fujii S
Mol Hum Reprod; 2003 Nov; 9(11):709-17. PubMed ID: 14561813
[TBL] [Abstract][Full Text] [Related]
32. Cellular senescence in usual type uterine leiomyoma.
Markowski DN; Helmke BM; Bullerdiek J
Fertil Steril; 2010 Nov; 94(6):e79; author reply e80. PubMed ID: 20850727
[No Abstract] [Full Text] [Related]
33. [Fibroblast growth factor gene expression in uterine leiomyomas].
Wolańska M; Bańkowska-Guszczyn E; Jaworski S
Ginekol Pol; 2008 Aug; 79(8):555-9. PubMed ID: 18819464
[TBL] [Abstract][Full Text] [Related]
34. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.
Lee BS; Nowak RA
J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas.
Maekawa R; Sato S; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Takaki E; Nakai A; Sugino N
PLoS One; 2013; 8(6):e66632. PubMed ID: 23818951
[TBL] [Abstract][Full Text] [Related]
36. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma.
Carbajo-García MC; García-Alcázar Z; Corachán A; Monleón J; Trelis A; Faus A; Pellicer A; Ferrero H
Fertil Steril; 2022 Feb; 117(2):433-443. PubMed ID: 34809976
[TBL] [Abstract][Full Text] [Related]
38. Molecular and Cellular Insights into the Development of Uterine Fibroids.
Machado-Lopez A; Simón C; Mas A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445194
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
[TBL] [Abstract][Full Text] [Related]
40. Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma.
Maekawa R; Yagi S; Ohgane J; Yamagata Y; Asada H; Tamura I; Sugino N; Shiota K
J Reprod Dev; 2011 Oct; 57(5):604-12. PubMed ID: 21685710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
